Maternal Oxygen Administration for Fetal Distress II

NACompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

October 31, 2021

Study Completion Date

December 31, 2021

Conditions
Oxygen Inhalation TherapyLabourFetal Distress
Interventions
DEVICE

tight-fitting simple facemask

Oxygen will be administered by facemask at 10 L/min oxygen. The therapy will continue until after delivery

Trial Locations (3)

Unknown

Department of Obstetrics and Gynecology, PLA Strategic Support Force Characteristic Medical Center, Beijing

Department of Obstetrics and Gynecology, Seventh Medical Center, Chinese PLA General Hospital, Beijing

Department of Obstetrics and Gynecology, Sixth Medical Center, Chinese PLA General Hospital, Beijing

All Listed Sponsors
lead

Navy General Hospital, Beijing

OTHER

NCT03764696 - Maternal Oxygen Administration for Fetal Distress II | Biotech Hunter | Biotech Hunter